Shandong Realcan Pharmaceutical Co., Ltd.



Quote for Shandong Realcan Pharmaceutical Co., Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002589
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002589 quote

Summary for Shandong Realcan Pharmaceutical Co., Ltd.

Shandong Realcan Pharmaceutical Co., Ltd. is a provider of pharmaceuticals direct distribution services. The Company operates its businesses primarily through the wholesale of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones, among others; the distribution of medical equipment, healthcare food and daily-used products; the wholesale of exercise equipment, cosmetics and disinfectants; the storage and distribution of pharmaceuticals, as well as the provision of ordinary freight services. The Company has two distribution molds: government-guided marketing and market-guided marketing. The Company operates its businesses primarily in China, with Shandong province as its major market.

Profile for Shandong Realcan Pharmaceutical Co., Ltd.

Full Name:Shandong Realcan Pharmaceutical Co., Ltd.
Full Name in Chinese:山东瑞康医药股份有限公司 Short Name in Chinese:瑞康医药
Symbol/Stock Code:
002589
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Han Xu
Secretary of the Board:
Zhou Yun
Phone:
+86-535-6737695
Fax:
+86-535-6737695
Official Website:www.realcan.cn
E-mail:stock@realcan.cn
Address:No. 326,Jichang Road, Zhifu District,YANTAI SHA 264004
IPO Subscription Date:
2011-06-01
Listing Date:
2011-06-10
IPO Issued Capital:
23800000
IPO Price:
20 CNY
IPO fees:
40906700 CNY
Money Raised by IPO:
476000000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
435093300 CNY
Open(Listing day):
21.81 CNY
Close(Listing day):
24.44 CNY
Diluted P/E ratio after IPO:
30.3000
Turnover rate(listing day):
89.84%

Financials for Shandong Realcan Pharmaceutical Co., Ltd.

UPDATE:2012-10-24 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
77.0027
84.0573
62.1092
44.7573
Net Profit Growth(%)
40.14
35.33
38.76
53.39
Return On Equity(ROE)(%)
8.72
10.31
20.98
19.13
Debt ratio(%)
71.24
63.15
79.99
77.48
Net Operating Cash Flow/Net Profit(%)
-397.03
-565.13
113.60
137.15

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.8210
1.0300
0.8900
0.7100
Diluted Earnings Per Share
0.0000
1.0400
0.9100
0.7400
Net Asset Value Per Share (NAVPS)
9.4100
8.6900
4.2300
3.3417
Additional Paid-In Capital Per Share
6.0041
6.0046
2.1706
2.1704
Retained Earnings Per Share
2.2464
1.5255
0.9565
0.1548
Net Cash Flow From Operatings Activities Per Share
-3.2600
-5.0600
1.0100
0.8800
Net Cash Flow Per Share
-0.3200
0.2288
0.9271
1.4778

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
3070.1328
2217.5452
1479.4783
1039.9631
Total Liabilities(Million)
2187.387
1400.437
1183.4445
805.78
Current Liabilities(Million)
2187.387
1400.437
1183.4445
805.78
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
260.8912
307.2657
349.6807
255.9602
Accounts Receivables(Million)
1837.1836
1338.7704
790.1586
531.856
Deposit Received(Million)
0.8117
0.3971
0.1387
9.6477
Other Receivables(Million)
12.1646
4.0349
1.996
7.7944
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
882.76
815.1844
296.0337
233.9162
Debt ratio(%)
71.24
63.15
79.99
77.48
Equity Ratio(%)
28.7500
36.7600
20.0000
22.4900
Current Ratio
1.3286
1.4983
1.1709
1.2102
Quick Ratio
1.1397
1.2834
1.0091
1.0545

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
3558.1578
2623.9038
2415.4891
1754.4755
Net Cash Flow From Operatings Activities(Million)
-305.723
-475.0319
70.557
61.3845
Net Cash Flow From Operatings Activities Change(%)
-26.98
-773.26
14.94
-223.08
Net Cash Flow(Million)
-30.0132
21.4603
64.8953
103.4477
Cash From Selling Commodities/Prime Revenue(%)
105.17
82.11
109.13
109.54
Net Cash Flow/Net Profit(%)
-38.98
25.53
104.49
231.13
Cash Flow From Investing Activities(Million)
-86.7656
-45.3814
-37.9785
-20.8947
Cash Flow From Financing Activities(Million)
362.4754
541.8735
32.3168
62.9579

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
3383.1282
3195.4481
2213.3827
1601.7308
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
68.7765
63.4259
39.7357
28.9964
Administrative Costs(Million)
44.1803
47.8306
33.3839
27.4526
Financing Costs(Million)
25.043
24.6044
18.6745
14.5332
Above Three Costs Change(%)
45.33
48.01
29.32
21.81
Operating Profit(Million)
106.6455
113.5546
85.1406
62.8892
Income From Investment(Million)
-
-
-
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
-3.9939
-1.1181
-1.9648
-2.7993
Total Profit(Million)
102.6517
112.4365
83.1758
60.0899
Corporate Income Tax(Million)
25.6241
28.4138
21.0442
15.2801
Net Profit(Million)
77.0027
84.0573
62.1092
44.7573
Gross Profit Ratio(%)
7.55
8.19
8.30
8.59
Operating Margin(%)
3.15
3.55
3.84
3.92
Return On Equity(ROE)(%)
8.72
10.31
20.98
19.13

Announcements for Shandong Realcan Pharmaceutical Co., Ltd.

Date: 2012-10-25
Title: EGM-ONLINE
The Company will hold the 5th Extraordinary General Meeting of 2012 at 14:30 on 13 November 2012.

Meeting agenda:
1. Continued use of partial idle raised funds to temporarily replenish working capital


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 06 November 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: from 09 November 2012 to 09 November 2012

The Company's shareholder may choose to vote online via the trading system of Shenzhen Stock Exchange or via the website of http://wltp.cninfo.com.cn.
Part I Voting via the trading system
Voting date: 13 November 2012
Voting code:362589
Voting abbreviation:Realcan Pharmaceutical voting
Voting process:
1. To input the "buy" instruction to begin voting
2. To input the serial number of the Investors Meeting proposals under the item of "subscription price" "1 share" for voting for, "2 shares" for voting against and "3 shares" for "abstention".

Part II Voting via the internet
Shareholders may choose the CA (certification authority) or service password for identity verification. As to the service password, shareholders may apply for a password on the website http://www.szse.cn or http://wltp.cninfo.com.cn.
Voting period: from 12 November 2012 to 13 November 2012.
Date: 2012-08-07
Title: EGM RESOLUTION
The Company held its 4th Extraordinary General Meeting of 2012 on 06 August 2012, during which the following proposal(s) was/were approved:
1. The Company's eligibility for non-public offering
2. Scheme for the Company's 2012 non-public offering
2.1. Stock type and par value
2.2. Issuance method and date
2.3. Issuance volume
2.4. Issuance targets
2.5. Base date and issuing price
2.6. Use and amount of raised funds
2.7. Profit distribution scheme after the issuance
2.8. Valid period of the resolution on the non-public offering
3. Preplan of the Company's non-public offering
4. Feasibility report on the use of funds to be raised from the Company's non-public offering
5. Statement on the use of previously raised funds
6. Authorization to the board to handle matters in relation to the non-public offering
7. Amendments to the Company's articles of association
8. Supplementary amendments to previous amendments to the Company's articles of association
Date: 2012-07-10
Title: EGM RESOLUTION
The Company held its 3rd Extraordinary General Meeting of 2012 on 09 July 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
2. The profit distribution policy and plan for the shareholders' profit return for the next three years(2012-2014).
Date: 2012-06-20
Title: EGM-SPOT
The Company will hold the 3rd Extraordinary General Meeting of 2012 at 10:00 on 09 July 2012.

Meeting agenda:
1. Amendments to the Company's articles of association
2. The profit distribution policy and plan for the shareholders' profit return for the next three years(2012-2014)

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 05 July 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 06 July 2012
Date: 2012-06-07
Title: RESTRICTED SHARE LISTING
Among the Company's 17315664 restricted shares to be unlocked on 11 June 2012, 17315664 of them will be tradable on the Shenzhen Stock Exchange on that day.
Date: 2012-05-23
Title: DIVIDEND IMPLEMENTATION (CASH ONLY)
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY1.00000000
2. Bonus issue from profit (share/10 shares): none
3. Bonus issue from capital reserve (share/10 shares): none


Record date: 28 May 2012
Ex-date: 29 May 2012
Payment date: 29 May 2012

10 percent withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable. Please refer to below details:
Tax on cash dividend/10 shares: CNY0.10000000(10 percent x CNY1.00000000)
Net cash dividend/10 shares after tax: CNY0.90000000(CNY1.00000000- CNY0.10000000)
Date: 2012-05-16
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 15 May 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 annual report and its summary
3. 2011 financial resolution report and 2012 financial budget report
4. 2011 profit distribution plan
5. Reappointment of audit firm
6. 2011 work report of the supervisory committee
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY1.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-04-25
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 25 April 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY1.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-04-25
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 10:00 on 15 May 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 annual report and its summary
3. 2011 financial resolution report and 2012 financial budget report
4. 2011 profit distribution plan
5. Reappointment of audit firm
6. 2011 work report of the supervisory committee
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY1.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 11 May 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 14 May 2012
Date: 2012-04-18
Title: EGM RESOLUTION
The Company held its 2nd Extraordinary General Meeting of 2012 on 17 April 2012, during which the following proposal(s) was/were approved:
1. Application for issue of private placement bonds to a bank
2. Application for credit business to banks
3. To temporarily replenish working capital with partial idle raised funds again
4. Amendments to the Company's articles of association.